Sudden Infant Death: all 80 studies
Page 1 of 1. Open to participants first (14), then studies with results posted, then the rest; newest registration first within each.
- A Study of Secondary Immunodeficiencies in Adults With Blood Cancers in Kazakhstan Who Have a Weakened Immune System (K-SIDE Study)Not yet recruitingNCT07868107
- Infant Safe Sleep in Pediatric Emergency DepratmentRecruitingNCT07779512Not applicable
- Supply Induced Demand in Intensive Care Unit: a Retrospective TrialNot yet recruitingNCT07768410
- Social Media and Risk-reduction Training for Preterm Infant Care PracticesNot yet recruitingNCT07420686Not applicable
- The Impact of the Nurse-Led "My Baby is Safe" Educational ProgramNot yet recruitingNCT07037914Not applicable
- Get Social Media and Risk-Reduction TrainingRecruitingNCT06618586Not applicable
- Identification of Genetic Variants Associated With Unexpected Infant Death SyndromeRecruitingNCT06244433
- An Extension Study of the Long-Term Safety, Tolerability, and Efficacy of Tividenofusp Alfa (DNL310) in Participants With Mucopolysaccharidosis Type II (MPS II) From Study DNLI-E-0002 or Study DNLI-E-0007Enrolling by invitationNCT06075537Phase 2/3
- Improving Pediatrician Counseling About Infant Safe Sleep Using the Electronic Medical RecordRecruitingNCT05503771Not applicable
- PEARL (PrEnAtal Enzyme Replacement Therapy for Lysosomal Storage Disorders)RecruitingNCT04532047Phase 1
- Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RICRecruitingNCT04528355
- Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal DemiseRecruitingNCT03775954
- Longitudinal Study of Neurodegenerative DisordersRecruitingNCT03333200
- Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCTRecruitingNCT01962415Phase 2
- Social Media and Risk Reduction Teaching-Enhanced ReachCompletedNCT04387552Not applicableResults posted
- Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-913 in Subjects With MPS IITerminatedNCT03041324Phase 1/2Results posted
- Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive ImpairmentCompletedNCT02055118Phase 2/3Results posted
- Carotid Structure and Function in MPS Syndromes: A Multicenter Study of the Lysosomal Disease NetworkCompletedNCT01586871Results posted
- An Extension Study of HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Idursulfase-IT in Conjunction With Elaprase in Pediatric Participants With Hunter Syndrome and Cognitive ImpairmentCompletedNCT01506141Phase 1/2Results posted
- Study of the Impact of Parental Note Taking on the Effectiveness of Anticipatory GuidanceCompletedNCT01014169Not applicableResults posted
- A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Hunter Syndrome Who Have Central Nervous System Involvement and Are Receiving Treatment With Elaprase®CompletedNCT00920647Phase 1/2Results posted
- An Observational Study Evaluating Anti-Idursulfase Serum Antibody Response in Hunter Syndrome PatientsCompletedNCT00882921Results posted
- Clinical Trial of Growth Hormone in MPS I, II, and VITerminatedNCT00748969Phase 2/3Results posted
- Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving IdursulfaseCompletedNCT00630747Phase 2/3Results posted
- Safety and Clinical Outcomes in Hunter Syndrome Patients 5 Years of Age and Younger Receiving Idursulfase TherapyCompletedNCT00607386Phase 4Results posted
- Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections.CompletedNCT00555061Phase 4Results posted
- Iduronate-2-sulfatase Enzyme Replacement Therapy in Mucopolysaccharidosis II (MPS II)CompletedNCT00069641Phase 2/3Results posted
- An Extension Study to Assess the Long-term Safety and Efficacy of Hunterase (Idursulfase Beta)CompletedNCT07344376Phase 3
- RGX-121-3102 Gene Therapy in Participants With MPS II (Hunter Syndrome)Active, not recruitingNCT07236606Phase 3
- The Effect of the Use of Mobile AppCompletedNCT07032402Not applicable
- Training About Sudden Infant Death SyndromeCompletedNCT06922682Not applicable
- Environmental Exposures and Sudden Unexpected Infant DeathActive, not recruitingNCT06708793
- JessieHug Feasibility and Usability AssessmentTerminatedNCT06466148Not applicable
- Incorporation of Safe Sleep Education Into m-Health TechnologyCompletedNCT06074211Not applicable
- Investigation of the Genetic Diseases in Infants With Unknown Cause of DeathActive, not recruitingNCT06060249
- The Effect of Video-Assisted Sudden Infant Death Syndrome Prevention Training Program and Counseling Practice on Mothers' Knowledge Level and Self-efficacy: Randomized Controlled StudyStatus unknownNCT05823051Not applicable
- A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II)Active, not recruitingNCT05371613Phase 2/3
- Safety and Efficacy of HMI-203 in ERT-Treated Adults With MPS IIWithdrawnNCT05238324Phase 1
- A Multi-cohort Study of Safety, Efficacy, PK and PD of GNR-055 in Patients With Mucopolysaccharidosis Type IIActive, not recruitingNCT05208281Phase 2/3
- MPS II ImmunophenotypingTerminatedNCT04976231
- Long-term Follow-Up for RGX-121Active, not recruitingNCT04597385
- Mucopolysaccharidosis Type II ObservationalWithdrawnNCT04591834
- RGX-121 Gene Therapy in Children 5 Years of Age and Over With MPS II (Hunter Syndrome)CompletedNCT04571970Phase 1/2
- A Study of Tividenofusp Alfa (DNL310) in Pediatric Participants With Hunter SyndromeActive, not recruitingNCT04251026Phase 1/2
- A Study of Potential Treatment-Responsive Biomarkers and Clinical Outcomes in Hunter SyndromeCompletedNCT04007536
- A Study of GC1111 in Hunter Syndrom PatientsCompletedNCT03920540Phase 3
- Improving Infant Sleep Safety With the Electronic Health RecordCompletedNCT03662048Not applicable
- CAMPSIITE™ RGX-121 Gene Therapy in Subjects With MPS II (Hunter Syndrome)Active, not recruitingNCT03566043Phase 2/3
- Mucopolysaccharidosis Type II Natural HistoryCompletedNCT03529786
- Effect of Crystalloids With Different SID on pH, and Urinary Electrolytes During General AnesthesiaCompletedNCT03507062Not applicable
- Infant Care Practices StudyCompletedNCT03494621Not applicable
- The Inclined Position in Case of Respiratory Discomfort in the One Year Less Infant : Study on the Profits and the Risks in the HomeStatus unknownNCT03482804
- Evaluation of Safe Sleep for Babies: a Bassinet Distribution and Education ProgramCompletedNCT03392727Not applicable
- Apparent Life Threatening Events, Sudden Infant Death Syndrome and Muscarinic ReceptorsTerminatedNCT03278977Not applicable
- Generations in Families Talking Safe SleepStatus unknownNCT03186469Not applicable
- Enhancing Safe Sleep Practices of Urban Low-Income MothersCompletedNCT03070639Not applicable
- Change in Serum Chloride Level After Loading Dose of Sterofundin Solution Compared With Normal Saline SolutionCompletedNCT02950974Not applicable
- Comparing Children's Book to Brochures for Safe Sleep Education in a Home Visiting ProgramCompletedNCT02376673Not applicable
- Safety and Dose Ranging Study of Insulin Receptor MoAb-IDS Fusion Protein in Patients With Hunter SyndromeCompletedNCT02262338Phase 1
- Assessing the Impact of Smoke-free Legislation on Perinatal Health in the NetherlandsCompletedNCT02189265
- Mucopolysaccharidosis (MPS) I, II, and VI Screening in a High-Risk Population With Previous Surgical Repair or Presence of Inguinal and/or Umbilical Hernia in Combination With Pediatric ENT Surgery (The HATT Project)TerminatedNCT02095015
- Sensory Integration (Processing) Disorder Among Children With Behavioral Insomnia and Children With Feeding DisorderStatus unknownNCT02040688
- Impact of Smoke-free Legislation on Early-life Mortality and Low Birth Weight in EnglandCompletedNCT02039583
- Re-enforcing Safe Sleep Practices for Caregivers With Tangible IncentivesCompletedNCT02010450Not applicable
- Lysosomal Storage Disease: Health, Development, and Functional Outcome Surveillance in Preschool ChildrenCompletedNCT01938014
- The Paediatric Virtual Autopsy TrialCompletedNCT01888380Not applicable
- Longitudinal Studies of Brain Structure and Function in MPS DisordersCompletedNCT01870375
- Improving the Self-Efficacy of African American Parents in Infant Supine SleepCompletedNCT01707173Not applicable
- Magnetic Resonance Imaging Autopsy StudyCompletedNCT01417962
- Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic DisordersTerminatedNCT01372228Phase 1/2
- Factors Influencing the Racial Disparity in Sudden Infant Death Syndrome (SIDS)CompletedNCT01361893Not applicable
- Reduce African-American Infant MortalityCompletedNCT01361880Not applicable
- Biomarkers for Hunter SyndromeTerminatedNCT01330277
- To Evaluate the Safety and Efficacy of GC1111 (Recombinant Human Iduronate-2-sulfatase) in Hunter Syndrome PatientsCompletedNCT01301898Phase 1/2
- Changes in Sleep Patterns and Stress in Infants Entering Child CareCompletedNCT01265277
- Do Pacifiers Protect From Sudden Infant Death Syndrome (SIDS) Through an Increase in Upper Airway Patency?Status unknownNCT01120938
- ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic DiseasesTerminatedNCT00654433Phase 3
- Influence of Pacifiers on Breastfeeding DurationCompletedNCT00306956Phase 3
- Parental Knowledge and Beliefs About Infant Sleep PositionCompletedNCT00005567Not applicable
- Incidence and Severity of Cardiorespiratory Events in Infants at Increased Epidemiological Risk for Sudden Infant Death Syndrome (SIDS)CompletedNCT00004392